{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Attention+Deficit%2FHyperactivity+Disorder%28ADHD%29&page=2", "query": { "condition": "Attention Deficit/Hyperactivity Disorder(ADHD)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Attention+Deficit%2FHyperactivity+Disorder%28ADHD%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-06-26T14:51:58.920Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00983814", "title": "Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of Carbidopa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Droxidopa+Carbidopa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chelsea Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 20, "start_date": "2009-10", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2024-04-18", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00983814" }, { "nct_id": "NCT02900144", "title": "Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Tourette Syndrome", "ADHD" ], "interventions": [ { "name": "Modified Comprehensive Behavioral Intervention for Tics", "type": "BEHAVIORAL" }, { "name": "Comprehensive Behavioral Intervention for Tics", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 17, "start_date": "2016-09", "completion_date": "2019-04-10", "has_results": false, "last_update_posted_date": "2021-09-16", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02900144" }, { "nct_id": "NCT07203092", "title": "Effects of Transcranial Photobiomodulation in ADHD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Active transcranial photobiomodulation", "type": "DEVICE" }, { "name": "Sham transcranial photobiomodulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Francisco Gonzalez-Lima, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "ALL", "summary": "18 Years to 44 Years" }, "enrollment_count": 140, "start_date": "2025-09-01", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07203092" }, { "nct_id": "NCT02618434", "title": "Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Attention Deficit Hyperactivity Disorder (ADHD)" ], "interventions": [ { "name": "SPN-810 (18 mg)", "type": "DRUG" }, { "name": "SPN-810 (36 mg)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Supernus Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Years to 12 Years" }, "enrollment_count": 297, "start_date": "2016-02-16", "completion_date": "2020-02-14", "has_results": true, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 32, "location_summary": "Chandler, Arizona • Little Rock, Arkansas • Imperial, California + 29 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Imperial", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Panorama City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02618434" }, { "nct_id": "NCT03047369", "title": "The Myelin Disorders Biorepository Project", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Leukodystrophy", "White Matter Disease", "Leukoencephalopathies", "4H Syndrome", "Adrenoleukodystrophy", "AMN", "ALD", "ALD Gene Mutation", "ALD (Adrenoleukodystrophy)", "X-linked Adrenoleukodystrophy", "X-ALD", "Adrenomyeloneuropathy", "Aicardi Goutieres Syndrome", "AGS", "Alexander Disease", "Alexanders Leukodystrophy", "AxD", "ADLD", "Canavan Disease", "CTX", "Cerebrotendinous Xanthomatoses", "Krabbe Disease", "GALC Deficiency", "Globoid Leukodystrophy", "TUBB4A-Related Leukodystrophy", "H-ABC - Hypomyelination, Atrophy of Basal Ganglia and Cerebellum", "HBSL", "HBSL - Hypomyelination, Brain Stem, Spinal Cord, Leg Spasticity", "LBSL", "Leukoencephalopathy With Brain Stem and Spinal Cord Involvement and High Lactate Syndrome (Disorder)", "Leukoencephalopathy With Brainstem and Spinal Cord Involvement and Lactate Elevation", "ALSP", "CSF1R Gene Mutation", "HCC - Hypomyelination and Congenital Cataract", "MLC1", "Megalencephalic Leukoencephalopathy With Subcortical Cysts", "MLD", "Metachromatic Leukodystrophy", "PMD", "Pelizaeus-Merzbacher Disease", "PLP1 Null Syndrome", "PLP1 Gene Duplication | Blood or Tissue | Mutations", "Pelizaeus Merzbacher Like Disease", "Peroxisomal Biogenesis Disorder", "Zellweger Syndrome", "Refsum Disease", "Salla Disease", "Sialic Storage Disease", "Sjögren", "Sjogren-Larsson Syndrome", "Van Der Knapp Disease", "Vanishing White Matter Disease", "Charcot-Marie-Tooth", "CMT", "Mct8 (Slc16A2)-Specific Thyroid Hormone Cell Transporter Deficiency", "Allan-Herndon-Dudley Syndrome", "Cadasil", "Cockayne Syndrome", "Multiple Sulfatase Deficiency", "Gangliosidoses", "GM2 Gangliosidosis", "BPAN", "Labrune Syndrome", "LCC", "Mucopolysaccharidoses", "TBCK-Related Intellectual Disability Syndrome" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 12000, "start_date": "2016-12-08", "completion_date": "2030-12-08", "has_results": false, "last_update_posted_date": "2025-10-23", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 23, "location_summary": "Los Angeles, California • Orange, California • Palo Alto, California + 18 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03047369" }, { "nct_id": "NCT05991167", "title": "EndeavorRx® Prospective Product Registry (\"Expedition EndeavorRx\")", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "ADHD" ], "interventions": [ { "name": "EndeavorRx", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Akili Interactive Labs, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 150, "start_date": "2022-06-01", "completion_date": "2025-12-31", "has_results": false, "last_update_posted_date": "2024-06-27", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05991167" }, { "nct_id": "NCT01019252", "title": "Skills Training for Adolescents With ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Cognitive Behavioral Therapy (CBT)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "14 Years to 18 Years" }, "enrollment_count": 66, "start_date": "2009-10", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2018-07-31", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01019252" }, { "nct_id": "NCT02096952", "title": "Methylphenidate ER Liquid Formulation in Adults With ASD and ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention-deficit/Hyperactivity Disorder", "Autism Spectrum Disorder" ], "interventions": [ { "name": "Methylphenidate extended-release liquid formulation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 15, "start_date": "2014-05", "completion_date": "2018-01", "has_results": true, "last_update_posted_date": "2024-07-01", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096952" }, { "nct_id": "NCT05793216", "title": "VestibulOTherapy: Vestibular Impact on Learning", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Vestibular Disorder", "Educational Problems", "Attention Deficit Disorder" ], "interventions": [ { "name": "VestibulOTherapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VestibulOTherapy", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "10 Years", "sex": "ALL", "summary": "6 Years to 10 Years" }, "enrollment_count": 15, "start_date": "2023-03-07", "completion_date": "2023-10-25", "has_results": false, "last_update_posted_date": "2023-03-31", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "La Crosse, Wisconsin", "locations": [ { "city": "La Crosse", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05793216" }, { "nct_id": "NCT04025814", "title": "dHealth Solution for Improving Parent Adherence to Behavioral Treatment for ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "CaregiverAssist", "type": "DEVICE" }, { "name": "Behavioral Parent Training (CLS Parent Group)", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "6 Years to 85 Years" }, "enrollment_count": 73, "start_date": "2020-08-01", "completion_date": "2024-11-12", "has_results": false, "last_update_posted_date": "2025-07-03", "last_synced_at": "2026-06-26T14:51:58.920Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04025814" } ] }